Multiple helminth infection of the skin causes lymphocyte hypo-responsiveness mediated by Th2 conditioning of dermal myeloid cells

PLoS Pathogens

Volumn 7, Issue 3, 2011, Pages

  Cook, Peter C ^a   Aynsley, Sarah A ^a   Turner, Joseph D ^a   Jenkins, Gavin R ^a   van Rooijen, Nico ^b   Leeto, Mosiuoa ^c   Brombacher, Frank ^c   Mountford, Adrian P ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CELL SURFACE RECEPTOR; CYTOKINE; IL4RA PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; EOSINOPHIL; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SKIN CELL; SKIN INFECTION; TH2 CELL; ANIMAL; ANTIGEN PRESENTING CELL; BAGG ALBINO MOUSE; DERMIS; GENETICS; IMMUNOLOGY; LYMPH NODE; MOUSE MUTANT; PARASITIC SKIN DISEASE; PARASITOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION;

MAMMALIA; MUS; SCHISTOSOMA; VERMES;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL PROLIFERATION; CYTOKINES; DERMIS; EOSINOPHILS; FEMALE; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELOID CELLS; RECEPTORS, CELL SURFACE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SIGNAL TRANSDUCTION; SKIN DISEASES, PARASITIC; TH2 CELLS;

EID: 79953273091     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001323     Document Type: Article

References (57)

1. Chitsulo L, Loverde P, Engels D, (2004) Schistosomiasis. Nat Rev Microbiol 2: 12-13.
2. Gryseels B, Polman K, Clerinx J, Kestens L, (2006) Human schistosomiasis. Lancet 368: 1106-1118.
3. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
4. Pearce EJ, MacDonald AS, (2002) The immunobiology of schistosomiasis. Nat Rev Immunol 2: 499-511.
5. Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, et al. (2007) Immunopathology of schistosomiasis. Immunol Cell Biol 85: 148-154.
6. Hewitson JP, Hamblin PA, Mountford AP, (2005) Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol 27: 271-280.
7. Hewitson JP, Hamblin PA, Mountford AP, (2007) In the absence of CD154, administration of interleukin-12 restores Th1 responses but not protective immunity to Schistosoma mansoni. Infect Immun 75: 3539-3547.
8. Incani RN, McLaren DJ, (1984) Histopathological and ultrastructural studies of cutaneous reactions elicited in naive and chronically infected mice by invading schistosomula of Schistosoma mansoni. Int J Parasitol 14: 259-276.
9. Hogg KG, Kumkate S, Anderson S, Mountford AP, (2003) Interleukin-12 p40 secretion by cutaneous CD11c+ and F4/80+ cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni. Infect Immun 71: 3563-3571.
10. Paveley RA, Aynsley SA, Cook PC, Turner JD, Mountford AP, (2009) Fluorescent imaging of antigen released by a skin-invading helminth reveals differential uptake and activation profiles by antigen presenting cells. PLoS Negl Trop Dis 3: e528.
11. Angeli V, Faveeuw C, Roye O, Fontaine J, Teissier E, et al. (2001) Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med 193: 1135-1147.
12. Jenkins SJ, Hewitson JP, Jenkins GR, Mountford AP, (2005) Modulation of the host's immune response by schistosome larvae. Parasite Immunol 27: 385-393.
13. Ramaswamy K, Kumar P, He YX, (2000) A role for parasite-induced PGE2 in IL-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni. J Immunol 165: 4567-4574.
14. Ferret-Bernard S, Curwen RS, Mountford AP, (2008) Proteomic profiling reveals that Th2-inducing dendritic cells stimulated with helminth antigens have a 'limited maturation' phenotype. Proteomics 8: 980-993.
15. Jenkins SJ, Mountford AP, (2005) Dendritic cells activated with products released by schistosome larvae drive Th2-type immune responses, which can be inhibited by manipulation of CD40 costimulation. Infect Immun 73: 395-402.
16. Jenkins SJ, Hewitson JP, Ferret-Bernard S, Mountford AP, (2005) Schistosome larvae stimulate macrophage cytokine production through TLR4-dependent and-independent pathways. Int Immunol 17: 1409-1418.
17. Anthony RM, Rutitzky LI, Urban JF Jr, Stadecker MJ, Gause WC, (2007) Protective immune mechanisms in helminth infection. Nat Rev Immunol 7: 975-987.
18. Maizels RM, Pearce EJ, Artis D, Yazdanbakhsh M, Wynn TA, (2009) Regulation of pathogenesis and immunity in helminth infections. J Exp Med 206: 2059-2066.
19. Paul WE, Zhu J, (2010) How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 10: 225-235.
20. Hewitson JP, Jenkins GR, Hamblin PA, Mountford AP, (2006) CD40/CD154 interactions are required for the optimal maturation of skin-derived APCs and the induction of helminth-specific IFN-gamma but not IL-4. J Immunol 177: 3209-3217.
21. Zhang M, Angata T, Cho JY, Miller M, Broide DH, et al. (2007) Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood 109: 4280-4287.
22. Huber S, Hoffmann R, Muskens F, Voehringer D, (2010) Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. Blood 116: 3311-3320.
23. Gordon S, (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35.
24. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, et al. (2002) IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol 3: 7.
25. Nair MG, Gallagher IJ, Taylor MD, Loke P, Coulson PS, et al. (2005) Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun 73: 385-394.
26. Kourilova P, Hogg KG, Kolarova L, Mountford AP, (2004) Cercarial dermatitis caused by bird schistosomes comprises both immediate and late phase cutaneous hypersensitivity reactions. J Immunol 172: 3766-3774.
27. Baumgart M, Tompkins F, Leng J, Hesse M, (2006) Naturally occurring CD4+Foxp3+ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J Immunol 176: 5374-5387.
28. Farah IO, Johansson M, Lovgren-Bengtson K, Hau J, (2000) Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response. Scand J Immunol 51: 237-243.
29. Farah IO, Mola PW, Kariuki TM, Nyindo M, Blanton RE, et al. (2000) Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4. J Immunol 164: 5337-5343.
30. Black CL, Mwinzi PN, Muok EM, Abudho B, Fitzsimmons CM, et al. (2010) Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni. PLoS Negl Trop Dis 4: e637.
31. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, et al. (2004) Helminth parasites-masters of regulation. Immunol Rev 201: 89-116.
32. Smith P, Walsh CM, Mangan NE, Fallon RE, Sayers JR, et al. (2004) Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J Immunol 173: 1240-1248.
33. Yang D, Chen Q, Su SB, Zhang P, Kurosaka K, et al. (2008) Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med 205: 79-90.
34. Nair MG, Du Y, Perrigoue JG, Zaph C, Taylor JJ, et al. (2009) Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung. J Exp Med 206: 937-952.
35. Pesce JT, Ramalingam TR, Wilson MS, Mentink-Kane MM, Thompson RW, et al. (2009) Retnla (relmalpha/fizz1) suppresses helminth-induced th2-type immunity. PLoS Pathog 5: e1000393.
36. He R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, et al. (2008) TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proc Natl Acad Sci U S A 105: 11875-11880.
37. Jessup HK, Brewer AW, Omori M, Rickel EA, Budelsky AL, et al. (2008) Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response. J Immunol 181: 4311-4319.
38. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, et al. (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367-1370.
39. Saenz SA, Siracusa MC, Perrigoue JG, Spencer SP, Urban JF Jr, et al. (2010) IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 464: 1362-1366.
40. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
41. Martinez FO, Helming L, Gordon S, (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27: 451-483.
42. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, et al. (2004) Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623-635.
43. Loke P, Gallagher I, Nair MG, Zang X, Brombacher F, et al. (2007) Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J Immunol 179: 3926-3936.
44. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, et al. (2009) Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 5: e1000371.
45. Sutherland TE, Maizels RM, Allen JE, (2009) Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies. Clin Exp Allergy 39: 943-955.
46. Anthony RM, Urban JF Jr, Alem F, Hamed HA, Rozo CT, et al. (2006) Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med 12: 955-960.
47. Cai Y, Kumar RK, Zhou J, Foster PS, Webb DC, (2009) Ym1/2 promotes Th2 cytokine expression by inhibiting 12/15(S)-lipoxygenase: identification of a novel pathway for regulating allergic inflammation. J Immunol 182: 5393-5399.
48. Reese TA, Liang HE, Tager AM, Luster AD, Van Rooijen N, et al. (2007) Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 447: 92-96.
49. Mantovani A, Sica A, Locati M, (2005) Macrophage polarization comes of age. Immunity 23: 344-346.
50. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686.
51. Taylor MD, Harris A, Nair MG, Maizels RM, Allen JE, (2006) F4/80+ alternatively activated macrophages control CD4+ T cell hyporesponsiveness at sites peripheral to filarial infection. J Immunol 176: 6918-6927.
52. Arora M, Chen L, Paglia M, Gallagher I, Allen JE, et al. (2006) Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells. Proc Natl Acad Sci U S A 103: 7777-7782.
53. Lan YY, Wang Z, Raimondi G, Wu W, Colvin BL, et al. (2006) "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol 177: 5868-5877.
54. Wang H, Peters T, Kess D, Sindrilaru A, Oreshkova T, et al. (2006) Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest 116: 2105-2114.
55. MacDonald AS, Maizels RM, (2008) Alarming dendritic cells for Th2 induction. J Exp Med 205: 13-17.
56. Mountford AP, Hogg KG, Coulson PS, Brombacher F, (2001) Signaling via interleukin-4 receptor alpha chain is required for successful vaccination against schistosomiasis in BALB/c mice. Infect Immun 69: 228-236.
57. Van Rooijen N, Sanders A, (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174: 83-93.